1. Articles from lydiaramsey125

    1-8 of 8
    1. UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid

      UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid
      • Microbiome-testing company uBiome's board now only has one independent director, following a raid of the company by the FBI in April.
      • In a letter to investors sent Tuesday, a special committee of uBiome's board of directors said that two board members, UCSF professor Joe DeRisi and early founder Witt Wisebram, have resigned...
      Read Full Article
    2. Bristol-Myers Squibb is Buying Celgene in a $74 Billion Deal

      Bristol-Myers Squibb is Buying Celgene in a $74 Billion Deal
      • Bristol-Myers Squibb has agreed to acquire Celgene, the drugmakers announced Thursday in a deal valued at $74 billion.
      • The deal will pay Celgene shareholders one BMS share and $50 cash for each Celgene share they own.
      • The deal combines a massive pharmaceutical company with a biotech giant, both of which have a big presence in cancer drug development...
      Read Full Article
    3. Cigna is Closing its $67 Billion Deal with Express Scripts, Creating a New Healthcare Giant

      Cigna is Closing its $67 Billion Deal with Express Scripts, Creating a New Healthcare Giant
      • Cigna is set to officially close its deal to acquire pharmacy benefits manager Express Scripts.
      • The deal was announced in March but took some time clearing regulatory hurdles from state insurance agencies as well as the Department of Justice.
      • The deal combines a health insurer and a company that helps negotiate lower prices for prescription drugs in the form of rebates on behalf of health plans.

      Cigna is about to close on its deal to acquire healthcare giant Express Scripts...

      Read Full Article
    4. A Healthcare Company That Fought an 18-Month Battle with an Activist Investor Just Struck a $5.7 Billion Deal to End The Fight

      A Healthcare Company That Fought an 18-Month Battle with an Activist Investor Just Struck a $5.7 Billion Deal to End The Fight

      Healthcare IT company Athenahealth reached an agreement with Veritas Capital and Elliott Management to be acquired in a $5.7 billion deal. The deal comes after a long-running push from Elliott for Athenahealth to sell itself. Under the two big investment firms, Athenahealth will be combined with Virence Health, a company Veritas acquired earlier this year. The Athenahealth saga is coming to a close...

      Read Full Article
      Mentions: Athenahealth
    5. Merck's Board Just Changed the Rules to Keep its CEO on Board After he Turns 65

      Merck's Board Just Changed the Rules to Keep its CEO on Board After he Turns 65
      • Merck CEO Kenneth Frazier plans to stay on in his role as CEO past December 2019, when he turns 65.
      • The pharma giant's board of directors had to overturn a mandatory CEO retirement policy in order for Frazier to stay on.
      • Frazier, who became CEO in 2011, gained national attention after he was the first to depart President Donald Trump now-disbanded manufacturing council...
      Read Full Article
      Mentions: Harvard retire Merck
    6. The $67 Billion Cigna-Express Scripts Merger Just Passed a Key Hurdle (CI, Esrx)

      The $67 Billion Cigna-Express Scripts Merger Just Passed a Key Hurdle (CI, Esrx)
      • Cigna and Express Scripts shareholders have voted to approve the companies' $67 billion merger.
      • The deal combines a health insurer and a company that helps negotiate lower prices for prescription drugs in the form of rebates on behalf of health plans.
      • The deal was in jeopardy for a week after billionaire Carl Icahn came out against the deal, saying it "may well rival the worst acquisitions in corporate history." He ultimately reversed his course...
      Read Full Article
    7. 'Losing direction': Allergan Investors are Unhappy After a Wild 4 Hour Takeover Drama

      'Losing direction': Allergan Investors are Unhappy After a Wild 4 Hour Takeover Drama
      • Allergan's stock closed down 4% on Thursday, after the pharma giant said it was "in the early stages of considering a possible offer" for UK-listed Shire, only to say four hours later that it wouldn't make an offer.
      • The drama extends what's been a tough year for the Botox-maker, with the stock vastly underperforming the broader biotech index...
      Read Full Article
    8. Breaking News -- Mylan's Shareholders Just Voted Against its Executive Pay, Which Included a $100 Million Package for its Chairman

      Breaking News -- Mylan's Shareholders Just Voted Against its Executive Pay, Which Included a $100 Million Package for its Chairman

      AMSTERDAM (Reuters) - Mylan NV shareholders voted to re-elect the generic drugmaker's board at its annual meeting on Thursday, despite a push to to vote down most of the directors.

      Shareholders also voted against a measure to approve the company's executive compensation. The shareholder campaign against Mylan's board picked up steam after Chairman Robert Coury's nearly $100 million pay package was disclosed earlier this year...

      Read Full Article
    1-8 of 8
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics in the News

    1. (5 articles) Board of Directors
    2. (4 articles) MDC Partners
    3. (4 articles) Board of Directors
    4. (3 articles) Investors
    5. (2 articles) Carl Icahn
    6. (2 articles) CVS
    7. (2 articles) Glass Lewis
    8. (2 articles) Merck
    9. (2 articles) Cigna
    10. (2 articles) Express Scripts
    11. (2 articles) Investors
    12. (2 articles) stake
    13. (2 articles) MDC Partners
    14. (2 articles) SEC
    15. (2 articles) Management
    16. (1 articles) Flower One
    17. (1 articles) emails
    18. (1 articles) human rights
    19. (1 articles) corporate governance
    20. (1 articles) Sale
  3. Popular Articles

  4. Picture Gallery

    Breaking News -- Mylan's Shareholders Just Voted Against its Executive Pay, Which Included a $100 Million Package for its Chairman 'Losing direction': Allergan Investors are Unhappy After a Wild 4 Hour Takeover Drama The $67 Billion Cigna-Express Scripts Merger Just Passed a Key Hurdle (CI, Esrx) Merck's Board Just Changed the Rules to Keep its CEO on Board After he Turns 65 A Healthcare Company That Fought an 18-Month Battle with an Activist Investor Just Struck a $5.7 Billion Deal to End The Fight Cigna is Closing its $67 Billion Deal with Express Scripts, Creating a New Healthcare Giant Bristol-Myers Squibb is Buying Celgene in a $74 Billion Deal UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid Victoria's Secret-parent L Brands Rockets Higher Following a Report That its Billionaire Owner is Looking to Sell the Brand Toshiba Machine Awaiting Approval for its Poison Pill Defense As SEC Curtails Shareholder Activism, Big Institutional Investors Must Act Will Potbelly be Pressured by a New Activist?